LeMaitre Vascular Inc
NASDAQ:LMAT

Watchlist Manager
LeMaitre Vascular Inc Logo
LeMaitre Vascular Inc
NASDAQ:LMAT
Watchlist
Price: 105.425 USD -1.55% Market Closed
Market Cap: 2.4B USD
Have any thoughts about
LeMaitre Vascular Inc?
Write Note

LeMaitre Vascular Inc
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

LeMaitre Vascular Inc
Operating Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
LeMaitre Vascular Inc
NASDAQ:LMAT
Operating Income
$49.6m
CAGR 3-Years
10%
CAGR 5-Years
18%
CAGR 10-Years
25%
Becton Dickinson and Co
NYSE:BDX
Operating Income
$2.9B
CAGR 3-Years
7%
CAGR 5-Years
6%
CAGR 10-Years
6%
Boston Scientific Corp
NYSE:BSX
Operating Income
$2.9B
CAGR 3-Years
20%
CAGR 5-Years
10%
CAGR 10-Years
11%
Stryker Corp
NYSE:SYK
Operating Income
$4.8B
CAGR 3-Years
11%
CAGR 5-Years
8%
CAGR 10-Years
8%
Abbott Laboratories
NYSE:ABT
Operating Income
$6.9B
CAGR 3-Years
-7%
CAGR 5-Years
10%
CAGR 10-Years
11%
Intuitive Surgical Inc
NASDAQ:ISRG
Operating Income
$2.1B
CAGR 3-Years
5%
CAGR 5-Years
10%
CAGR 10-Years
14%
No Stocks Found

LeMaitre Vascular Inc
Glance View

Market Cap
2.4B USD
Industry
Health Care

LeMaitre Vascular, Inc. engages in the provision of medical devices and human tissue cryopreservation services. The company is headquartered in Burlington, Massachusetts and currently employs 450 full-time employees. The company went IPO on 2006-10-19. The firm develops, manufactures and markets vascular devices to address the needs of vascular surgeons, and to a lesser degree, other specialties, such as cardiac surgeons, general surgeons and neurosurgeons. The company sold its principal product in the United States, Europe, the United Kingdom, Canada and Asia Pacific. The firm sales its products and services primarily through a direct sales force. Its products and services offering includes Allografts, Angioscopes, Balloon Catheters for Embolectomy and Thrombectomy, Balloon Catheters for Occlusion and Perfusion, Bovine Grafts, Vascular and Cardiac Patches, Carotid Shunts, Closure Systems, Ovine Vascular Grafts, Polyester Vascular Grafts, ePTFE Vascular Grafts, Radiopaque Tape, and Valvulotomes.

LMAT Intrinsic Value
54.085 USD
Overvaluation 49%
Intrinsic Value
Price

See Also

What is LeMaitre Vascular Inc's Operating Income?
Operating Income
49.6m USD

Based on the financial report for Sep 30, 2024, LeMaitre Vascular Inc's Operating Income amounts to 49.6m USD.

What is LeMaitre Vascular Inc's Operating Income growth rate?
Operating Income CAGR 10Y
25%

Over the last year, the Operating Income growth was 46%. The average annual Operating Income growth rates for LeMaitre Vascular Inc have been 10% over the past three years , 18% over the past five years , and 25% over the past ten years .

Back to Top